This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

29 November - 9 December, 2021
Delivered in a 100% Digital Format as a Free-to-Attend Webinar Series

Lucie Grindes
Cell line development PhD student, BioReliance® End-to-End Solutions at Merck

Agenda Sessions

  • Increase of clone titer by lowering strength of selection marker: an improvement of the CHOZN® CHO K1 cell line development platform